Section Arrow
PTCT.NASDAQ
- PTC Therapeutics
Quotes are at least 15-min delayed:2024/10/31 19:25 EDT
Last
 39.92
-0.74 (-1.82%)
Day High 
41.07 
Prev. Close
40.66 
1-M High
43.4 
Volume 
465.48K 
Bid
37.68
Ask
42.18
Day Low
39.7 
Open
40.49 
1-M Low
34.5697 
Market Cap 
3.13B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 40.21 
20-SMA 38.96 
50-SMA 36.42 
52-W High 43.4 
52-W Low 18.15 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.31/-6.53
Enterprise Value
5.15B
Balance Sheet
Book Value Per Share
-12.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
937.82M
Operating Revenue Per Share
5.60
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 19:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.